Study of outcomes in anti-LGI1 brain inflammation
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study follows people newly diagnosed with anti-LGI1 encephalitis (a brain inflammation) to see how well they do over time. It aims to learn more about the condition and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have anti-LGI1 encephalitis, a specific type of brain inflammation.
- You must be newly diagnosed and currently in the active (acute) phase of the illness.
- You must be willing to sign a consent form to participate.
- You cannot have had epilepsy, stroke, a brain injury, or other nervous system disease before this diagnosis.
- You cannot have other related antibodies, such as anti-CASPR2.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with autoimmune encephalitis, a condition where the immune system attacks the brain. It aims to collect information about this disease to learn more about it and how to treat it.
This research study looks for new markers in the blood of people with autoimmune encephalitis (a condition where the immune system attacks the brain). It aims to better understand what causes the disease and find new ways to diagnose it.
This study looks at adults with autoimmune encephalitis who needed care in the intensive care unit (ICU). It aims to find patterns and markers that help predict how patients will do.
This study looks at how the immune system works in certain neurological conditions, including autoimmune encephalitis and related nerve disorders. Researchers may use blood and/or spinal fluid samples, especially when antibodies are present or can’t be found, to better understand what’s driving the illness.
This observational study follows people with various immune-related neurological conditions, such as multiple sclerosis, neuromyelitis optica, and autoimmune encephalitis. It aims to better understand these diseases and their progression over time.
This study looks at how autoimmune encephalitis affects brain metabolism using a special PET scan. It aims to better understand the condition in people who were recently diagnosed.
Hear when a new Autoimmune Encephalitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.